Endometriosis and adenomyosis : (Record no. 93904)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02204nam a22001817a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 221205b2022 |||||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9783030972356 |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
Classification number | WP 390 |
245 ## - TITLE STATEMENT | |
Title | Endometriosis and adenomyosis : |
Subtitle | global perspectives across the lifespan |
260 ## - PUBLICATION INFORMATION | |
Place of publication | Cham, Switzerland : |
Publisher | Springer, |
Date | 2022 |
300 ## - PHYSICAL DESCRIPTION | |
Physical description | xxiv, 611p |
520 ## - ABSTRACT | |
Abstract | Although endometriosis and adenomyosis are often assessed under the same umbrella, the epidemiology, clinical manifestations and management strategies of endometriosis and adenomyosis occur differently during the life cycle of a woman. Endometriosis can be diagnosed at many points across the lifespan, including adolescence and the climacterium, as well as pregnancy. Being associated with potential adverse health effects, different clinical presentations requiring different therapeutic approaches render it imperative to tailor management strategies for each period of the lifespan: in utero and early life, puberty and adolescence, reproductive years, pregnancy, late reproductive age, and the menopause.<br/>This book provides comprehensive insight into the general aspects, diagnosis and treatment modalities of endometriosis and adenomyosis in all stages of a woman's life - a unique element of its approach. Thematic sections discuss the basics of diagnosis and management of both endometriosis and adenomyosis from birth through menopause, including aspects of fertility preservation, sexual dysfunction, psychological considerations and prevention. The current pharmaceutical approaches and efficacy are presented, including progestins, oral contraceptives, aromatase inhibitors and GnRH agonists and antagonists. The final section provides current practice guidelines for the management of both conditions as well as an investigation into future research and clinical strategies.<br/>Taking a truly global perspective, Endometriosis and Adenomyosis will be a valuable resource for reproductive endocrinologists, infertility specialists and obstetricians and gynecologists worldwide. |
650 #4 - SUBJECT HEADINGS | |
9 (RLIN) | 6051 |
Subject term | Endometriosis |
650 #4 - SUBJECT HEADINGS | |
9 (RLIN) | 13493 |
Subject term | Reproductive health |
650 #4 - SUBJECT HEADINGS | |
9 (RLIN) | 6329 |
Subject term | Gynaecology |
700 ## - ADDED PERSONAL NAME | |
Added personal author | Oral, Engin |
Relator term | Editor |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Suppress in OPAC | Do not Suppress in OPAC |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Cost, normal purchase price | Total Checkouts | Total Renewals | Full call number | Barcode | Checked out | Date last seen | Date last borrowed | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
National Library of Medicine | Hirson Library (St Helier) | Hirson Library (St Helier) | Shelves | 05/12/2022 | 119.45 | 1 | 2 | WP 390 | 042224 | 12/09/2023 | 02/06/2023 | 02/06/2023 | 05/12/2022 | Book |